Nottingham, United Kingdom

Eric C Wilmshurst

This inventor holds 5 USPTO granted patents. Top assignee: The Boots Company Plc. Active years: 1984-1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eric C Wilmshurst. Retrieved from https://idiyas.com/inventor/eric-c-wilmshurst

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.7

ph-index = 5

Forward Citations = 74(Granted Patents)


Company Filing History:


Years Active: 1984-1989

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Eric C Wilmshurst

Introduction

Eric C Wilmshurst is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of therapeutic agents, particularly in the treatment of depression. With a total of 5 patents to his name, Wilmshurst's work has garnered attention in the pharmaceutical industry.

Latest Patents

Wilmshurst's latest patents focus on compounds of formula I, which include various alkyl, alkenyl, and cycloalkyl groups. These compounds demonstrate therapeutic activity in treating depression. The pharmaceutical compositions and processes for preparing these compounds are also disclosed in his patents, showcasing his innovative approach to addressing mental health issues.

Career Highlights

Wilmshurst is associated with The Boots Company Plc, where he has been instrumental in developing new therapeutic agents. His work has not only advanced the understanding of depression treatment but has also contributed to the broader pharmaceutical landscape.

Collaborations

Throughout his career, Wilmshurst has collaborated with notable colleagues, including James Edward Jeffery and Antonin Kozlik. These partnerships have further enriched his research and development efforts.

Conclusion

Eric C Wilmshurst's contributions to the field of therapeutic agents highlight his innovative spirit and dedication to improving mental health treatments. His patents and collaborations reflect a commitment to advancing pharmaceutical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…